AstraZeneca to Establish $1.5 Billion ADC Manufacturing Facility in Singapore
AstraZeneca has announced plans to construct a $1.5 billion manufacturing facility in Singapore dedicated to producing antibody-drug conjugates (ADCs), a …
#Biologics
What are the ADC drugs?
The antibody-drug conjugates (ADCs) market continues to rise globally, but ADCs are not a new thing. Why has ADC been surging …
Three Insights For Immuno-oncology Drug Discovery
Immunotherapies are hot property. Immuno-oncology is the crown jewel. But the road to riches, and more importantly cancer cures, is …
Chinese Biotech Innovent Biologics, Inc. Raises USD 260M To Accelerate Biologics Development
Chinese biopharmaceutical industry investment landscape has been marked by a new record -- USD $260M Series D investment raised by …